AGP Picks
View all

French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on July 22, 2026

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026
BioCryst to Report Second Quarter 2026 Financial Results on August 5
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
 Bunzl Canada Surpasses $2M Raised for Pediatric Brain Tumour Research
RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call
Bunzl Canada dépasse les 2 M$ amassés pour la recherche sur les tumeurs cérébrales pédiatriques
Supportive Cancer Care Takes Center Stage as Members of the National Coalition Together for Supportive Cancer Care Ring the Nasdaq Closing Bell
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
Acentra Health Appoints Sreedevi Hegde as Senior Vice President – India Country Head
Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results
ReBio Pharma appoints leading ocular oncologist Professor Mandeep Sagoo as Chief Medical Officer
Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

French Guiana Wellness Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.